Is sentinel node biopsy feasible in endometrial cancer? Results in 26 patients;La biopsie du ganglion sentinelle dans les cancers de l'endomètre est-elle faisable? Résultats sur 26 cas

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 34, Issue 8, 2005, Pages 768-774

  Bats, A S ^a   Clement D ^a   Larousserie, F ^a   Lefrere Belda M A ^a   Faraggi, M ^a   Froissart, M ^a   Lecuru F ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Endometrial cancer; Laparoscopy; Lymphoscintigraphy; Sentinel lymph node biopsy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; EVALUATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOSCINTIGRAPHY; PREOPERATIVE PERIOD; SENTINEL LYMPH NODE BIOPSY;

EID: 29444448407     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0368-2315(05)82952-7     Document Type: Article

References (24)

1. Gould EA, Winship T, Philbin PH, Kerr HH. Observations on a "sentinel node" in cancer of the parotid. Cancer 1960; 13: 77-8.
2. Giuliano AE, Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-8.
3. Burke TW, Levenback C, Tornos C, Morris M, Wharton JT, Gershenson DM. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol 1996; 62: 169-73.
4. Lurain JR, Rice BL, Rademaker AW, Poggensee LE, Schink JC, Miller DS. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet Gynecol 1991; 78: 63-9.
5. Boente MP, Yordan ELJ, McIntosh DG, Grendys ECJ, Orandi YA, Davis S, et al. Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical envolvement. Gynecol Oncol 1993; 51: 316-22.
6. Chen Q, de la Rochefordiere A, Mouret-Fourme E, Durand JC, Clough K, Asselain B, et al. Prognostic factors in endometrial cancer : a propos of 206 cases treated at the Curie Institute. Bull Cancer 1995; 82: 717-23.
7. Sigurdsson K, Sigurdardottir B, Steinsson S, Benediktsdottir K, Sigurvinsson T, Sigvaldason H. Survival and prognostic factors of endometrial cancer patients in Iceland 1964-1985: can attendance at population-based Pap-smear screening affect survival? Int J Cancer 1998; 79: 166-74.
8. International Federation of gynecologists and obstetricians. Uterine Corpus cancer staging. Int J Gynaecol Obstet 1989; 28: 189-93.
9. Fédération nationale des centres de lutte contre le cancer. Standards, options et recommandations. Cancers de l'endomètre. Paris : John Ubbey Euronext, 2001.
10. Van Diest PJ, Peterse HL, Borgstein PJ, Hoekstra O, Meijer CJ. Pathological investigation of sentinel lymph nodes. Eur J Nucl Med 1999; 26: S43-9.
11. De Hullu JA, Doting E, Piers DA, Hollema H, Aalders JG, Koops HS, et al. Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva. J Nucl Med 1998; 39: 1381-85.
12. Yabushita H, Shimazu M, Yamada H, Sawaguchi K, Nogushi M, Nakanishi M. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol Oncol 2001; 80: 139-44.
13. Cartron G, Leblanc E, Ferron G, Martel P, Narducci F, Querleu D. Complications of laparoscopic lymphadenectomy in gynaecologic oncology. A series of 1102 procedures in 915 patients. Gynecol Obstet Fertil. 2005; [Epub ahead of print].
14. Pelosi E, Arena V, Baudino B, Bello M, Gargiulo T, Giusti, et al. Preliminary study of sentinel node identification with 99mTc colloid and blue dye in patients with endometrial cancer. Tumori 2002; 88: S9-10.
15. Barranger E, Cortez A, Grahek D, Callard P, Uzan S, Darai E. Laparoscopic Sentinel Node Procedure using a combinaison of patent blue and radiocolloid in women with endometrial cancer. Ann Surg Oncol 2004; 11: 344-49.
16. Holub Z, Kliment L, Lukac J, Voracek J. Laparoscopically-assisted intraoperative lymphatic mapping in endometrial cancer: preliminary results. Eur J Gynaecol Oncol 2001; 22: 118-21.
17. Holub Z, Jabor A, Kliment L. Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: a pilot study. Eur J Gynaecol Oncol 2002; 23: 53-7.
18. Lelievre L, Camatte S, Le Frere-Belda MA, Kerrou K, Froissart M, Taurelle R, et al. Sentinel lymph node biopsy in cervical and endometrial cancers : a feasibility study. Bull Cancer 2004; 91: 379-84.
19. Niikura H, Okamura C, Akahira J, Takano T, Ito K, Okamura K, et al. Sentinel lymph node detection in early cervical cancer with combination 99mTc phytate and patent blue. Gynecol Oncol 2004; 94: 528-32.
20. Holub Z, Jabor A, Lukac J, Kliment L. Laparoscopic detection of sentinel lymph nodes using blue dye in women with cervical and endometrial cancer. Med Sci Monit 2004; 10: 587-91.
21. Hirahatake K, Hareyama H, Sakuragi N, Nishiya M, Makinoda S, Fujimoto S. A clinical and pathologic study on para-aortic lymph node metastasis in endometrial carcinoma. J Surg Oncol 1997; 65: 82-7.
22. Mariani A, Webb MJ, Keeney GL, Podratz KC. Routes of lymphatic spread: a study of 112 consecutive patients with endometrial cancer. Gynecol Oncol 2001; 81: 100-4.
23. Gonzalez Bosquet J, Keeney GL, Mariani A, Webb MJ, Cliby WA. Cytokeratin staining of resected lymph nodes may improve the sensitivity of surgical staging for endometrial cancer. Gynecol Oncol 2003; 91: 518-25.
24. Gargiulo T, Giusti M, Bottero A, Leo L, Brokaj L, Armellino F, et al. Sentinel Lymph Node (SLN) laparoscopic assessment early stage in endometrial cancer. Minerva Ginecol 2003; 55: 259-62.